Study suggests new treatments for jaw tumors
Nature Genetics
May 26, 2014
Two genes linked to ameloblastomas, tumors of the jaw, are reported in a paper published online this week in Nature Genetics. The results suggest promising treatment options for these destructive jaw tumors.
Ameloblastomas are rare, benign tumors that often lead to facial disfigurement. Robert West and colleagues identified two genes, SMO and BRAF, that are often mutated in ameloblastomas. In their samples, tumors of the upper jaw tended to have SMO mutations, whereas the lower jaw tumors tended to have BRAF mutations. For each gene, the researchers identified an FDA-approved drug that can inhibit the mutant form in human cells. More testing is needed to see if these drugs can help ameloblastoma patients.
doi:10.1038/ng.2986
Research highlights
-
Jun 18
Climate change: Cleaner fuels may reduce impact of aviation on climate warmingCommunications Earth＆Environment
-
Jun 18
Health: 2014 FIFA World Cup associated with higher number of heart attacks in GermanyScientific Reports
-
Jun 18
Paleontology: New species of giant rhino discovered from 26.5-million-year-old fossilsCommunications Biology
-
Jun 17
Astronomy: ‘Great Dimming’ of Betelgeuse caused by dust veilNature
-
Jun 17
Environment: Flow interrupted for more than half of the world’s riversNature
-
Jun 16
Environment: EU agricultural imports vulnerable to future climate changeNature Communications
